Vir Biotechnology IncNASDAQ:VIR
- LAST PRICE7.9800
- TODAY'S CHANGE (%)0.1600 (2.0460%)
- Bid / Lots7.9800/ 2
- Ask / Lots7.9900/ 12
- Open / Previous Close7.9900 / 7.8200
- Day Range
- 52 Week Range
- Volume528,480
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VIR |
|---|---|---|
| 09:32 ET | 9063 | 7.92 |
| 09:34 ET | 2936 | 7.915 |
| 09:36 ET | 651 | 7.86 |
| 09:38 ET | 1509 | 7.79 |
| 09:39 ET | 1014 | 7.815 |
| 09:41 ET | 1179 | 7.79 |
| 09:43 ET | 500 | 7.81 |
| 09:45 ET | 5709 | 7.84 |
| 09:48 ET | 2411 | 7.87 |
| 09:50 ET | 6532 | 7.87 |
| 09:52 ET | 8524 | 7.92 |
| 09:54 ET | 299 | 7.91 |
| 09:56 ET | 2050 | 7.9 |
| 09:57 ET | 2902 | 7.89 |
| 09:59 ET | 2154 | 7.88 |
| 10:01 ET | 700 | 7.878 |
| 10:03 ET | 800 | 7.84 |
| 10:06 ET | 1563 | 7.88 |
| 10:08 ET | 600 | 7.86 |
| 10:10 ET | 1956 | 7.89 |
| 10:12 ET | 846 | 7.89 |
| 10:14 ET | 436 | 7.88 |
| 10:15 ET | 750 | 7.87 |
| 10:17 ET | 600 | 7.89 |
| 10:19 ET | 100 | 7.88 |
| 10:21 ET | 4121 | 7.895 |
| 10:24 ET | 1790 | 7.9 |
| 10:26 ET | 9117 | 7.88 |
| 10:28 ET | 924 | 7.88 |
| 10:30 ET | 217 | 7.88 |
| 10:32 ET | 4006 | 7.89 |
| 10:33 ET | 919 | 7.88 |
| 10:35 ET | 1300 | 7.88 |
| 10:37 ET | 3017 | 7.9 |
| 10:39 ET | 1750 | 7.89 |
| 10:42 ET | 1500 | 7.885 |
| 10:44 ET | 800 | 7.87 |
| 10:46 ET | 100 | 7.866 |
| 10:48 ET | 200 | 7.875 |
| 10:50 ET | 1200 | 7.9 |
| 10:51 ET | 400 | 7.89 |
| 10:53 ET | 1200 | 7.9 |
| 10:55 ET | 3533 | 7.9 |
| 10:57 ET | 4250 | 7.915 |
| 11:00 ET | 3591 | 7.95 |
| 11:02 ET | 1657 | 7.96 |
| 11:04 ET | 3920 | 7.92 |
| 11:08 ET | 2811 | 7.895 |
| 11:09 ET | 300 | 7.895 |
| 11:11 ET | 4240 | 7.89 |
| 11:13 ET | 1150 | 7.92 |
| 11:15 ET | 100 | 7.92 |
| 11:18 ET | 625 | 7.94 |
| 11:20 ET | 500 | 7.95 |
| 11:22 ET | 2367 | 7.935 |
| 11:24 ET | 1000 | 7.935 |
| 11:26 ET | 1233 | 7.935 |
| 11:27 ET | 1200 | 7.94 |
| 11:31 ET | 800 | 7.93 |
| 11:33 ET | 4040 | 7.94 |
| 11:36 ET | 1403 | 7.92 |
| 11:38 ET | 300 | 7.91 |
| 11:40 ET | 180 | 7.905 |
| 11:42 ET | 1474 | 7.89 |
| 11:44 ET | 424 | 7.9 |
| 11:45 ET | 500 | 7.91 |
| 11:49 ET | 1125 | 7.91 |
| 11:51 ET | 4647 | 7.915 |
| 11:56 ET | 925 | 7.94 |
| 11:58 ET | 503 | 7.9388 |
| 12:00 ET | 4846 | 7.96 |
| 12:02 ET | 100 | 7.96 |
| 12:03 ET | 1662 | 7.955 |
| 12:05 ET | 1714 | 7.95 |
| 12:07 ET | 781 | 7.959 |
| 12:09 ET | 2138 | 7.945 |
| 12:12 ET | 300 | 7.95 |
| 12:14 ET | 1195 | 7.945 |
| 12:18 ET | 138 | 7.945 |
| 12:20 ET | 400 | 7.95 |
| 12:21 ET | 200 | 7.96 |
| 12:23 ET | 6595 | 7.96 |
| 12:25 ET | 1310 | 7.98 |
| 12:27 ET | 5168 | 7.975 |
| 12:30 ET | 5031 | 7.95 |
| 12:32 ET | 1652 | 7.95 |
| 12:34 ET | 8996 | 7.975 |
| 12:38 ET | 1820 | 7.965 |
| 12:39 ET | 3700 | 7.975 |
| 12:41 ET | 3650 | 7.98 |
| 12:43 ET | 2196 | 8 |
| 12:45 ET | 1461 | 7.9901 |
| 12:48 ET | 1589 | 8.004635 |
| 12:50 ET | 1450 | 8.005 |
| 12:52 ET | 2182 | 8.01 |
| 12:54 ET | 2155 | 8.02 |
| 12:56 ET | 400 | 8.03 |
| 12:57 ET | 7003 | 8.005 |
| 12:59 ET | 2097 | 8.01 |
| 01:01 ET | 1640 | 7.99 |
| 01:03 ET | 280 | 7.99 |
| 01:06 ET | 500 | 7.99 |
| 01:10 ET | 4534 | 7.99 |
| 01:12 ET | 6068 | 8 |
| 01:14 ET | 19758 | 8 |
| 01:15 ET | 2929 | 8 |
| 01:17 ET | 1212 | 8.005 |
| 01:19 ET | 1294 | 7.995 |
| 01:21 ET | 771 | 7.99 |
| 01:24 ET | 4741 | 7.995 |
| 01:26 ET | 400 | 8 |
| 01:28 ET | 2886 | 7.985 |
| 01:30 ET | 100 | 7.985 |
| 01:33 ET | 599 | 7.99 |
| 01:37 ET | 1606 | 8 |
| 01:39 ET | 2108 | 7.995 |
| 01:44 ET | 2667 | 8 |
| 01:46 ET | 1912 | 8 |
| 01:48 ET | 300 | 8.005 |
| 01:50 ET | 2595 | 8 |
| 01:51 ET | 500 | 8 |
| 01:53 ET | 2012 | 7.995 |
| 01:57 ET | 3551 | 7.97 |
| 02:00 ET | 4029 | 7.97 |
| 02:02 ET | 8031 | 8.02 |
| 02:04 ET | 748 | 8.03 |
| 02:06 ET | 500 | 8.045 |
| 02:08 ET | 300 | 8.0499 |
| 02:09 ET | 653 | 8.04 |
| 02:13 ET | 2101 | 8.06 |
| 02:18 ET | 3000 | 8.065 |
| 02:20 ET | 26427 | 8.015 |
| 02:22 ET | 700 | 8.015 |
| 02:24 ET | 2381 | 8 |
| 02:26 ET | 4439 | 8.01 |
| 02:27 ET | 300 | 8.005 |
| 02:29 ET | 100 | 8.005 |
| 02:31 ET | 200 | 8.005 |
| 02:33 ET | 740 | 8.0092 |
| 02:36 ET | 100 | 8.005 |
| 02:38 ET | 4789 | 8 |
| 02:42 ET | 3441 | 8.01 |
| 02:44 ET | 100 | 8.0116 |
| 02:45 ET | 1307 | 8.015 |
| 02:47 ET | 3974 | 8.015 |
| 02:49 ET | 7229 | 8.005 |
| 02:51 ET | 225 | 8.015 |
| 02:54 ET | 1744 | 8.009 |
| 02:56 ET | 4807 | 8.01 |
| 02:58 ET | 529 | 8.015 |
| 03:00 ET | 1206 | 8.01 |
| 03:02 ET | 3213 | 8.005 |
| 03:03 ET | 900 | 8.005 |
| 03:05 ET | 4991 | 7.995 |
| 03:07 ET | 593 | 8 |
| 03:09 ET | 3062 | 8 |
| 03:12 ET | 1678 | 8 |
| 03:14 ET | 1804 | 8 |
| 03:16 ET | 1100 | 8 |
| 03:18 ET | 3065 | 8 |
| 03:23 ET | 11194 | 7.99 |
| 03:25 ET | 300 | 7.995 |
| 03:27 ET | 3742 | 7.995 |
| 03:32 ET | 1529 | 8 |
| 03:34 ET | 3459 | 7.99 |
| 03:36 ET | 800 | 7.985 |
| 03:38 ET | 200 | 7.98 |
Today
Yesterday
Sep 4, 2024
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031, from 8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
Aug 22, 2024
Vir Biotechnology to Participate in the Morgan Stanley 22(nd) Annual Global Healthcare Conference, from 8:05AM ET on Thursday Aug 22, 2024 by Dow Jones
8:05AM ET on Thursday Aug 22, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vir Biotechnology Inc | 1.1B | -2.2x | --- |
Prothena Corporation PLC | 1.1B | -20.6x | --- |
Gyre Therapeutics Inc | 1.2B | -15.0x | --- |
Zymeworks Inc | 831.3M | -7.9x | --- |
Arcutis Biotherapeutics Inc | 1.3B | -5.0x | --- |
Silence Therapeutics PLC | 883.7M | -14.9x | --- |
Company Information
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Contact Information
- Headquarters
- 1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
- Phone
- 415-906-4324
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Vicki Sato
- Chief Executive Officer, Director
- Marianne De Backer
- Executive Vice President, Chief Technology Officer
- Ann Hanly
- Executive Vice President, Chief Scientific Officer
- Jennifer Towne
- Executive Vice President and Chief Business Officer
- Jeffrey Calcagno
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1B |
|---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.48 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 13.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
